The Claim
Human vascular pericytes in vitro secrete osteoprotegerin and inhibit osteoclast differentiation from CD14+ monocytes, and this inhibition is reversed by OPG-neutralizing antibodies, indicating that pericytes regulate vascular calcification balance through suppression of bone resorption.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Human vascular pericytes release osteoprotegerin, which blocks the formation of bone-resorbing cells from CD14+ monocytes, and this blocking effect is eliminated when osteoprotegerin is neutralized, demonstrating a direct role in controlling vascular calcification by suppressing bone resorption.
See the scientific wording
Human vascular pericytes in vitro secrete osteoprotegerin and inhibit osteoclast differentiation from CD14+ monocytes, an effect reversed by OPG-neutralizing antibodies, suggesting pericytes may regulate vascular calcification balance by suppressing bone resorption.
When blood vessel walls are damaged by inflammation and mineral buildup, special cells called pericytes turn into bone-like cells and release a protein that blocks another protein from activating bone-dissolving cells. This stops the bone-dissolving cells from forming, so mineral deposits become hard and stable instead of weak and prone to rupture.
What the research says
1 studyIn stable artery plaques, cells called pericytes release a protein that stops bone-breaking cells from forming, which helps keep the plaque from becoming dangerous. The study found more of these cells and this protein in stable plaques than in unstable ones.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.